Rheumatology
From the Journals
Study highlights disparities in U.S. lupus mortality
Sex, race, and geographic region were independent risk factors for SLE mortality.
Feature
Stopping anti-TNF drugs in PsA has high rebound risk
A preponderance of evidence suggests how difficult it is for PsA patients with low disease activity to discontinue the drugs.
Feature
Biosimilars poised to save $54 billion over the next decade
But uncertainty points to savings ranging from $24 billion to $150 billion.
Conference Coverage
Rheumatoid arthritis increases risk of COPD hospitalizations
The risk of COPD hospitalizations was 47% higher in individuals with rheumatoid arthritis.
Guidelines
British Society of Rheumatology issues first U.K. lupus guideline
The guidelines are the first from any medical society for systemic lupus erythematosus overall since 2008.
From the Journals
High ‘nocebo’ effect observed when patients knowingly switch to a biosimilar
A “nocebo” response to switching from an originator biologic to its biosimilar may be hampering persistence to biosimilar therapy, new research...
Conference Coverage
VIDEO: Dr. Andrew Kaunitz’s top lessons from NAMS 2017
PHILADELPHIA – Dr. Kaunitz shares what he learned about migraines, breast imaging, and the connection between type 2 diabetes and the risk for...
From the Journals
Abatacept shows potential in refractory myositis
A small phase 2b trial provides evidence to warrant further study.
News
FDA approves first extended-release steroid injection for OA knee pain
The microsphere-based formulation is intended to prolong the release of triamcinolone acetonide inside the synovial fluid.
From the Journals
PBC linked to low BMD, increased risk of osteoporosis
The mechanisms underpinning the metabolic or biochemical relationships are not known.
From the Journals
Febuxostat prevents early gout flares
The study is the first randomized, controlled trial examining the effects of urate-lowering therapy in patients with early gout.